Hyperglycemia During Acute Pancreatitis and Progression to Early-Onset Diabetes After Recovery: Preliminary Findings From the Diabetes Related to Acute Pancreatitis and Its Mechanisms (DREAM) Study
Diabetes Care · 01.06.2026 · 49 (6) · 1040-1047
DOI: 10.2337/dc25-2885 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Diabetes Care, online erschienen am 06.04.2026. Verfasst von Kathleen M Dungan und 26 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes & Metabolism, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH. Hauptthemen laut MEDLINE: Diabetes Mellitus, Hyperglycemia, Pancreatitis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Themen: Diabetes mellitus
Abstract (Originalsprache)
OBJECTIVE Hyperglycemia during acute pancreatitis (HDAP) likely reflects both stress hormone responses and pancreatic islet injury, distinguishing it from typical stress-induced hyperglycemia. The aim of this study was to determine the prevalence of HDAP and its prognostic significance for early-onset diabetes following acute pancreatitis (AP). RESEARCH DESIGN AND METHODS Diabetes Related to Acute Pancreatitis and Its Mechanisms (DREAM) is a prospective multicenter study examining the development of diabetes following AP. This analysis included 395 participants without prior diabetes with an AP episode, focusing on their glucose levels during the event. Two definitions of HDAP were examined: peak glucose >140 mg/dL (HDAP140) and >200 mg/dL (HDAP200). Outpatient glycemic status after recovery (median: 111 days post-AP) was evaluated using fasting glucose, oral glucose tolerance test, and HbA1c. RESULTS HDAP140 and HDAP200 were present in 37.5% and 7.1% of participants, respectively. Age, race, etiology, and AP severity were significant predictors of HDAP140. Among participants with HDAP140, 14.8% developed early-onset diabetes after AP recovery vs. 1.2% in those without (P = 0.0001). In those with HDAP200, 42.9% developed early-onset diabetes vs. 3.5% in those without (P = 0.0001). The absence of HDAP140 and HDAP200 was associated with negative predictive values of 99% and 97%, respectively, for diabetes. CONCLUSIONS HDAP can be common in individuals without diabetes and is associated with early-onset diabetes following AP. Individuals without HDAP have a low risk of diabetes short term, while those with HDAP200 are at high risk. Monitoring glycemia during AP can identify individuals best suited for early targeted postdischarge care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes & Metabolism, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.
- Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA.
- Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, Penn State College of Medicine, Hershey, PA.
- Department of Pediatrics, Division of Pediatric Endocrinology, and Department of Surgery, University of Minnesota Medical School, Minneapolis, MN.
- Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh School of Medicine, Pittsburgh, PA.
- Division of Gastroenterology, Hepatology, and Nutrition, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.
ORCID-Profile: Kathleen M Dungan, Frederico G S Toledo
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Dungan, K. M., Chinchilli, V. M., Pichardo-Lowden, A., Raja-Khan, N., Bellin, M. D., Yadav, D., Hart, P. A., Basina, M., Buxbaum, J. L., Casu, A., Evans-Molina, C., Conwell, D. L., Fogel, E. L., Forsmark, C. E., Goodarzi, M. O., Kalyani, R. R., Layden, B. T., Lord, S. M., Papachristou, G. I., …, & Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC)* (2026). Hyperglycemia During Acute Pancreatitis and Progression to Early-Onset Diabetes After Recovery: Preliminary Findings From the Diabetes Related to Acute Pancreatitis and Its Mechanisms (DREAM) Study. Diabetes Care, 49(6), 1040-1047. https://doi.org/10.2337/dc25-2885
Vancouver
Dungan KM, Chinchilli VM, Pichardo-Lowden A, Raja-Khan N, Bellin MD, Yadav D, et al. Hyperglycemia During Acute Pancreatitis and Progression to Early-Onset Diabetes After Recovery: Preliminary Findings From the Diabetes Related to Acute Pancreatitis and Its Mechanisms (DREAM) Study. Diabetes Care. 2026;49(6):1040-1047. doi:10.2337/dc25-2885
BibTeX
@article{Dungan2026,
author = {Dungan, Kathleen M and Chinchilli, Vernon M and Pichardo-Lowden, Ariana and Raja-Khan, Nazia and Bellin, Melena D and Yadav, Dhiraj and Hart, Phil A and Basina, Marina and Buxbaum, James L and Casu, Anna and Evans-Molina, Carmella and Conwell, Darwin L and Fogel, Evan L and Forsmark, Chris E and Goodarzi, Mark O and Kalyani, Rita R and Layden, Brian T and Lord, Sandra M and Papachristou, Georgios I and Park, Walter G and Pratley, Richard and Singh, Vikesh K and Speake, Cate and Trikudanathan, Guru and Laughlin, Maren and Toledo, Frederico G S and Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC)*, Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC)*},
title = {Hyperglycemia During Acute Pancreatitis and Progression to Early-Onset Diabetes After Recovery: Preliminary Findings From the Diabetes Related to Acute Pancreatitis and Its Mechanisms (DREAM) Study},
journal = {Diabetes Care},
year = {2026},
volume = {49},
number = {6},
pages = {1040--1047},
doi = {10.2337/dc25-2885}
}
EUVIMED